Mahoney Michael F's Form 4 filing
Boston Scientific Corp (BSX) · filed Oct 5, 2021
- Accession no.
- 0001225208-21-012913
- Filed
- Oct 5, 2021
- Trade date
- Oct 4, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $8.63M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahoney Michael FCIK 0001533022 | Director, Officer (Chairman, President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | MOption exerciseAcquired | +134,988 | $6.28 | +$847,724.64 | 2,216,810 | Direct | |
| Oct 4, 2021 | Common Stock | MOption exerciseAcquired | +66,054 | $7.39 | +$488,139.06 | 2,282,864 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −97,838 | $42.43F3 | −$4,151,266.34 | 2,185,026 | Direct | |
| Oct 4, 2021 | Common Stock | SSaleDisposed | −103,204 | $43.39F4 | −$4,478,021.56 | 2,081,822 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2021 | Common Stock | MOption exerciseDisposed | −134,988 | $0.00 | $0 | 134,988 | Direct | |
| Oct 4, 2021 | Common Stock | MOption exerciseDisposed | −66,054 | $0.00 | $0 | 396,322 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.02 to $43.01, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.02 to $43.68, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.